Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J LaFrance

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cancer Research|October 1, 1986
Differential cytotoxicity and DNA-damaging effects produced in human cells of the Mer+ and Mer- phenotypes by a series of 1-aryl-3-alkyltriazenesN W Gibson, J A Hartley, R J LaFrance, et al.
The American Journal of Gastroenterology|February 1, 1985
Warfarin absorption after massive small bowel resectionD M Lutomski, R J LaFrance, R H Bower, et al.
Anti-Cancer Drug Design|October 1, 1985
Triazene metabolism. V. Chemical and biological properties of N,N-bis-[(1-aryl-3-methyltriazen-3-yl)-methyl]-methylamines: potential prodrugs for the cytotoxic monomethyltriazenesH W Manning, L M Cameron, R J LaFrance, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|March 1, 1990
Fat emulsion effects on prothrombin time in warfarin anticoagulated patients: an in vitro studyM A Cotto, D M Lutomski, J E Palascak, et al.
Anti-Cancer Drug Design|October 1, 1985
Triazene metabolism. IV. Derivatives of hydroxymethyltriazenes: potential prodrugs for the active metabolites of the anti-tumour triazene, DTICL M Cameron, R J LaFrance, C M Hemens, et al.
The Journal of Surgical Research|May 1, 1990
Addition of L-glutamine to total parenteral nutrition and its effects on portal insulin and glucagon and the development of hepatic steatosis in ratsS J Li, M S Nussbaum, D W McFadden, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cancer Research|October 1, 1986
Differential cytotoxicity and DNA-damaging effects produced in human cells of the Mer+ and Mer- phenotypes by a series of 1-aryl-3-alkyltriazenesN W Gibson, J A Hartley, R J LaFrance, et al.
The American Journal of Gastroenterology|February 1, 1985
Warfarin absorption after massive small bowel resectionD M Lutomski, R J LaFrance, R H Bower, et al.
Anti-Cancer Drug Design|October 1, 1985
Triazene metabolism. V. Chemical and biological properties of N,N-bis-[(1-aryl-3-methyltriazen-3-yl)-methyl]-methylamines: potential prodrugs for the cytotoxic monomethyltriazenesH W Manning, L M Cameron, R J LaFrance, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|March 1, 1990
Fat emulsion effects on prothrombin time in warfarin anticoagulated patients: an in vitro studyM A Cotto, D M Lutomski, J E Palascak, et al.
Anti-Cancer Drug Design|October 1, 1985
Triazene metabolism. IV. Derivatives of hydroxymethyltriazenes: potential prodrugs for the active metabolites of the anti-tumour triazene, DTICL M Cameron, R J LaFrance, C M Hemens, et al.
The Journal of Surgical Research|May 1, 1990
Addition of L-glutamine to total parenteral nutrition and its effects on portal insulin and glucagon and the development of hepatic steatosis in ratsS J Li, M S Nussbaum, D W McFadden, et al.
Pageof 1